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Abstract
On February 19th 2020, the Iranian Ministry of Health and Medical Education (MoHME) has announced the first 2
cases of SARS-CoV-2, a novel emerging coronavirus which causes an infection termed as COVID-19, in Qom city. As
such, the Iranian government, through the establishment of the “National Headquarters for the management and
control of the novel Coronavirus”, has started implementing policies and programs for the prevention and control
of the virus. These measures include schools and universities closure, reduced working hours, and increased
production and delivery of equipment such as masks, gloves and hygienic materials for sterile environments. The
government has also made efforts to divulge high-quality information concerning the COVID-19 and to provide
laboratories and hospitals with diagnostic kits and adequate resources to treat patients. However, despite such
efforts, the number of cases and deaths has progressively increased with rising trends in total confirmed cases and
deaths, as well as in new daily cases and deaths associated with the COVID-19. Iran is a developing country and its
economic infrastructure has been hit hardly by embargo and sanctions. While developed countries have allocated
appropriate funding and are responding adequately to the COVID-19 pandemics, Iran has experienced a serious
surge of cases and deaths and should strive to provide additional resources to the health system to make
healthcare services more accessible and to increase the fairness of that access. All relevant actors and stakeholders
should work together to fight this disease.
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Background
Since late December 2019, a novel coronavirus (SARS-
CoV-2), causing a generally mild but sometimes life-
threatening infection (termed as COVID-19) has quickly
spread out from the epicenter, Wuhan (People’s Repub-
lic of China), to other countries [1]. On February 19th
2020, the Iranian Ministry of Health and Medical Educa-
tion (MoHME) has announced the first 2 COVID-19
cases in Qom city, and the Iranian government, through
the establishment of the “National Headquarters for the
management and control of the novel Coronavirus”, has
started implementing policies and programs for the pre-
vention and control of the virus [2]. These measures in-
clude schools and universities closure, reduced working
hours, and increased production and delivery of equip-
ment such as masks, gloves and hygienic materials for
sterile environments. The government has also made ef-
forts to divulge high-quality information concerning the
COVID-19 and to provide laboratories and hospitals
with diagnostic kits and adequate resources to treat pa-
tients. However, despite such efforts, the number of
cases and deaths has progressively increased [2, 3].
Since the beginning of the outbreak, health policy- and
decision-makers began to implement intervention pol-
icies to prevent, control and treat people in the commu-
nity. The government has started injecting new funding,
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: masoudbehzadifar@gmail.com
1Social Determinants of Health Research Center, Lorestan University of
Medical Sciences, Khorramabad, Iran
Full list of author information is available at the end of the article
Behzadifar et al. International Journal for Equity in Health           (2020) 19:61 
https://doi.org/10.1186/s12939-020-01181-9
being aware of the risks that the disease could pose to
the health and other sectors [3]. As a first step, the gov-
ernment allocated 5 billion Tomans to the National
Headquarters for the management and control of the
outbreak and the country’s medical universities to coun-
teract the burden of the COVID-19 and strengthen the
healthcare system. This funding was employed to buy
masks, disinfectants and related equipment. Given the
population of about 13 million people in Tehran, the
capital of Iran and the population density in this metro-
politan area, 5 billion Tomans were allocated to equip
hospitals and provide essential supplies and rewards to
healthcare providers. Also, in the third step, further 5
billion Tomans were allocated to better manage disease
control in Qom and Gilan provinces where initially the
number of patients was high. Also, the MoHME pro-
vided 5 billion Tomans to compensate for physicians,
nurses and health personnel in controlling the outbreak
[2, 4].
To prevent and control the COVID-19, Iranian policy-
and decision-makers decided to quarantine people. Many
people were not able to go to work. For this reason, espe-
cially poor people experienced serious troubles buying
food and other necessities [3]. Therefore, the government
decided to provide monthly financial assistance to poor
people. Another set of policies was the allocation of 100
billion Tomans and insurance subsidies to the MoHME to
prevent the spread of the coronavirus [4].
The Supreme Council for Health and Food Security,
along with a special counsel for the COVID-19, has put
some essential policies on the agenda to support food
security of vulnerable groups, including delays in char-
ging bills such as electricity, repayment of bank loan
payments, and giving small amounts of money to vulner-
able groups. It should be noted that the government’s
capacity to provide such a support has declined due to
significant reductions in oil prices and decreased oil sell-
ing due to sanctions [3].
In Iran, health policy- and decision-makers are trying
to use new financial resources to provide all services.
The health system is also providing favourable or free
conditions for people who cannot afford to pay for ser-
vices. With the allocation of new funds, insurers play a
major role in protecting patients [5]. Facilitating access
to services for many people is a way for further promot-
ing and enhancing justice and equity in health in Iran
[6]. However, due to Iran’s sanctions, many health sector
activities that require financial exchanges and transac-
tions are in many cases not possible [7]. Many countries
around the world, the United Nations and the World
Health Organization (WHO) have called for the lifting
of sanctions to better deal with the disease [8]. Despite
all these problems, the government in Iran has been
working to provide new funding to address the COVID-
19 [2, 4].
Governmental funding in Iran is mainly dependent on
oil revenues, which have declined with the increasing
prevalence rate of the COVID-19 and the slump in glo-
bal production, and oil prices have fallen to their lowest
level in the last decades [3, 8, 9]. This is equivalent to re-
ducing income and creating new costs due to the burden
of disease. One of the most important financing policies
in different countries is to implement programs that do
not deprive people of access to health services due to in-
creased out-of-pocket (OOP) payments. Financing the
health system is a very important key to ensuring equity
in the delivery of health services [10]. However, the
COVID-19 pandemics is having a huge impact on differ-
ent parts of the country, which should strive to ensure
flexibility in financing the health system and compen-
sating for the increased costs of disease-related ser-
vices [11]. A very positive point in the Iranian health
system is the attention paid in recent years to the
issue of health. The launch of the HTP, the increase
of new funding to this sector, especially in the light
of the COVID-19 crisis, indicate that the implementa-
tion of health policies requires serious government
support, commitment and prioritization of this crisis
[5].
Iran, as other developing countries, has to face short-
age of healthcare personnel, especially nurses [12–14].
The presence of a nurse in wards such as the intensive
care unit (ICU) can be of great help in better managing
COVID-19 patients. Doctors, nurses and other staff are
at the frontline and are working around the clock to
help improve patients’ health and reduce mortality.
However, unfortunately, a number of dedicated doctors
have lost their lives [15].
In order to cope with the shortage of manpower in the
health system, the Iranian government increased the
number of students that could be admitted in various
fields of medical sciences. The government also allowed
MoHME to employ 10,000 people to help improve
health services, especially in deprived areas [16].
Before the launch of the Health Transformation Plan
(HTP) in 2014, there were about 5000 ICU beds. Follow-
ing the implementation of the HTP, with the allocation
of funds to the health sector, beds have been increased
by 42% up to 8000, with this increasing trend continuing
during the COVID-19 crisis, even though the number of
beds is still far from an ideal situation (about 15,000
ICU beds would be needed). Also, the overall number of
hospital beds has significantly increased by 25% from
108,000 to more than 130,000, with about 50,000 old
beds being renovated. Another major challenge of the
Iranian health system in the past was the shortage of
ambulances, with 30 air ambulances bases being recently
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established in Iran. Hospitals have been equipped also
with CT, which is crucial for diagnosing the COVID-19
and clinical records have been computerized. To per-
form an active follow-up in urban and rural areas and to
ensure that poor people are guaranteed access, the
MoHME has established an electronic health record sys-
tem during the HTP. Data from this electronic system
were combined with data from the Civil Registry Office
as well as economic data. Families in various geograph-
ical areas were tracked by telephone, and their family’s
symptoms were checked. People with current or future
early symptoms were called to access to selected health
centers; in poor areas, people were granted access to
diagnostic and treatment services and were given the ad-
dresses of centers where they could be examined. These
health centers are part of the country’s health network,
which has been developed in rural areas since long time,
whereas it has been established in some urban areas (es-
pecially those marginalized) in recent years [17, 18].
To better cope with its challenges, the Iran’s health
sector has made efforts to improve decision-making pro-
cesses and the implementation of health policies, with
the MoHME as the most important actor coordinating
the other sections.
Moreover, in the last four decades sanctions have im-
pacted on Iran’s health sector, limiting the purchase of
safety equipment, masks, gloves, clothes for doctors and
nurses, as well as medicines, ventilators and diagnostic
testing kits. Despite efforts by the WHO and other inter-
national organisms to limit these sanctions, embargo
policies are still affecting the health sector in Iran.
Conclusion
Iran is a developing country and its economic infrastruc-
ture has been hit hardly by embargo and sanctions.
While developed countries have allocated appropriate
funding and are responding adequately to the COVID-
19 pandemics, Iran has experienced a serious surge of
cases and deaths and should strive to provide additional
resources to the health system to make services more ac-
cessible and to increase the fairness of that access. All
relevant actors and stakeholders must work together to
fight this disease.
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